In BKPyV-, EBV- and HCV-associated malignancies, some authors have focused on the p16 protein, which inhibits the normal cell cycle, in order to evaluate the correlation of this biological marker with classical clinicopathological parameters (tumor stage, tumor grade, disease progression) [24,36,79]. This evidence concerns the gene CDKN2A and neoplasm.